Cargando…
Expression and Change of miRs 145, 221 and 222 in Hypertensive Subjects Treated with Enalapril, Losartan or Olmesartan
miR profile could be associated to CV risk, and also to prognosis/outcome in response to therapeutic approach. We aimed to evaluate if anti-hypertensive drugs enalapril, losartan or olmesartan have effects on monocyte miR profile in essential hypertensives without target organ involvement. For this...
Autores principales: | Mandraffino, Giuseppe, Lo Gullo, Alberto, Cinquegrani, Maria, D’Ascola, Angela, Sinicropi, Davide, Imbalzano, Egidio, Blando, Giuseppe, Campo, Giuseppe Maurizio, Morace, Carmela, Giuffrida, Clemente, Campo, Salvatore, Squadrito, Giovanni, Scuruchi, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389596/ https://www.ncbi.nlm.nih.gov/pubmed/34440064 http://dx.doi.org/10.3390/biomedicines9080860 |
Ejemplares similares
-
Circulating progenitor cells in hypertensive subjects: Effectiveness of a treatment with olmesartan in improving cell number and miR profile in addition to expected pharmacological effects
por: Mandraffino, Giuseppe, et al.
Publicado: (2017) -
Endocan Promotes Pro-Tumorigenic Signaling in Lung Cancer Cells: Modulation of Cell Proliferation, Migration and lncRNAs H19 and HULC Expression
por: Aliquò, Federica, et al.
Publicado: (2023) -
Endocan Knockdown Down-Regulates the Expression of Angiogenesis-Associated Genes in Il-1ß Activated Chondrocytes
por: Scuruchi, Michele, et al.
Publicado: (2023) -
Abnormal left ventricular global strain during exercise-test in young healthy smokers
por: Mandraffino, Giuseppe, et al.
Publicado: (2020) -
PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy
por: Toscano, Arianna, et al.
Publicado: (2022)